Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Pharmaceutical Retailers

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, comprising medicines, vitamins, medical devices, and test kits; and offers consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers. The company also provides wholesale cash and carry; diagnostic, pathological, and laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. It operates stores in Telangana, Andhra Pradesh, Karnataka, Tamil Nadu, West Bengal, Maharashtra, Orissa, Madhya Pradesh, Chhattisgarh, Kerala, and Puducherry, as well as online platform. The company was incorporated in 2006 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for MEDPLUS
Revenue projections for MEDPLUS

With MedPlus Health Services Limited's revenues forecasted to be lower than last year's, investors are expected to be cautious. A decline in revenue typically harms the company's bottom line, reducing profitability and making investors less confident about the company's ability to sustain its financial health.

Financial Ratios:

currentRatio 3.001000
forwardPE 32.688324
debtToEquity 72.133000
earningsGrowth 0.241000
revenueGrowth 0.235000
grossMargins 0.262290
operatingMargins 0.050000
trailingEps 18.270000
forwardEps 25.544290

MEDPLUS's current ratio is 3.001, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting MEDPLUS has no trouble covering its short-term financial obligations.
MedPlus Health Services Limited's positive earnings and revenue growth indicate that the company is expected to continue expanding its business. These trends reflect strong financial health, with increasing profits and sales suggesting sustained growth and success for MedPlus Health Services Limited.
With a forward EPS greater than its trailing EPS, MEDPLUS is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.

Price projections:

Price projections for MEDPLUS
Price projections for MEDPLUS

The current price of MEDPLUS, in relation to its projections, presents a neutral outlook. There are no discernible risks or opportunities at this stage, indicating that investors may need to await further developments to make informed decisions regarding their positions in the stock.

Recommendation changes over time:

Recommendations trend for MEDPLUS
Recommendations trend for MEDPLUS


MEDPLUS has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view MEDPLUS as a stable option to park their money and potentially benefit from the company's continued growth and profitability.